Nov 1, 2018Novo Nordisk's operating profit decreased by 6% in Danish kroner and increased by 2% in local currencies in the first nine months of 2018Adjusting for severance costs related to lay-offs in the third quarter of 2018, operating profit increased by 4% in local currencies.
- Oct 22, 2018Saxenda® is the first and only FDA-approved medicine in a pen indicated to help adults lose weight and keep it off
Jun 23, 2018Tresiba® demonstrated significantly lower A1C and rates of hypoglycaemia versus insulin glargine U-300 in real-world evidence studyAdults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in A1C and a 30% lower rate of hypoglycaemic episodes after starting basal insulin
Visit the download center to download Novo Nordisk video and more
Sign up to receive our new alerts